This is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms ...

For many people suffering from asthma, the winter months and the colder air can trigger asthma symptoms and flare-ups, which ...

Asthma sufferers have become the subject of a new clinical study using AI to create personalised treatment plans for patients ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company ...

The result could be deadly. Then there are the logistical burdens of self-administering a therapy. Xolair, one of the asthma therapies impacted by Blue Cross Blue Shield’s policy, must be kept ...

A new treatment for severe dust mite allergy has been recommended by NICE, for patients whose symptoms have not been helped ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown that salbutamol was more effective than ipratropium in asthma treatment.

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

supported the real-world utility of tralokinumab for the treatment of atopic dermatitis. Blood tests for cyclic adenosine monophosphate may be a simple and useful option for diagnosing asthma and ...